Long-term clinical and anatomic outcome of birdshot chorioretinopathy

JAMA Ophthalmology

Volumn 132, Issue 1, 2014, Pages 57-62

  Tomkins Netzer, Oren ^a,b,c   Taylor, Simon R J ^a,b,d   Lightman, Sue ^a,b,c  

^a MOORFIELDS EYE HOSPITAL   (United Kingdom)

^b ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ADULT; ARTICLE; BEST CORRECTED VISUAL ACUITY; BIRDSHOT CHORIORETINOPATHY; CATARACT; CENTRAL RETINAL THICKNESS; CHORIORETINOPATHY; CLINICAL ARTICLE; DISEASE SEVERITY; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAOCULAR PRESSURE; LONG TERM CARE; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SHORT COURSE THERAPY; VISUAL ACUITY; VISUAL FIELD; VISUAL IMPAIRMENT;

CHORIORETINITIS; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HLA-A ANTIGENS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VISUAL ACUITY; VISUAL FIELDS;

EID: 84892683821     PISSN: 21686165     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaophthalmol.2013.6235     Document Type: Article

References (27)

1. Rothova A, Van Schooneveld MJ. The end stage of birdshot retinochoroidopathy. Br J Ophthalmol. 1995;79(11):1058-1059.
2. Ryan SJ, Maumenee AE. Birdshot retinochoroidopathy. Am J Ophthalmol. 1980;89(1):31-45. (Pubitemid 10160102)
3. Brézin AP, Monnet D, Cohen JH, Levinson RD. HLA-A29 and birdshot chorioretinopathy. Ocul Immunol Inflamm. 2011;19(6):397-400.
4. Shah KH, Levinson RD, Yu F, et al. Birdshot chorioretinopathy. Surv Ophthalmol. 2005;50(6):519-541. (Pubitemid 41532320)
5. Rothova A, Berendschot TT, Probst K, van Kooij B, Baarsma GS. Birdshot chorioretinopathy: long-term manifestations and visual prognosis. Ophthalmology. 2004;111(5):954-959. (Pubitemid 38586691)
6. Thorne JE, Jabs DA, Kedhar SR, Peters GB, Dunn JP. Loss of visual field among patients with birdshot chorioretinopathy. Am J Ophthalmol. 2008;145(1):23-28.
7. Thorne JE, Jabs DA, Peters GB, Hair D, Dunn JP, Kempen JH. Birdshot retinochoroidopathy: ocular complications and visual impairment. Am J Ophthalmol. 2005;140(1):45-51.
8. Kiss S, Ahmed M, Letko E, Foster CS. Long-term follow-up of patients with birdshot retinochoroidopathy treated with corticosteroid-sparing systemic immunomodulatory therapy. Ophthalmology. 2005;112(6):1066-1071. (Pubitemid 40797463)
9. Comander J, Loewenstein J, Sobrin L. Diagnostic testing and disease monitoring in birdshot chorioretinopathy. Semin Ophthalmol. 2011;26(4-5):329- 336.
10. Oh KT, Christmas NJ, Folk JC. Birdshot retinochoroiditis: long term follow-up of a chronically progressive disease. Am J Ophthalmol. 2002;133(5):622-629. (Pubitemid 34462010)
11. Gordon LK, Goldhardt R, Holland GN, Yu F, Levinson RD. Standardized visual field assessment for patients with birdshot chorioretinopathy. Ocul Immunol Inflamm. 2006;14(6):325-332. (Pubitemid 44949890)
12. Gordon LK, Monnet D, Holland GN, Brézin AP, Yu F, Levinson RD. Longitudinal cohort study of patients with birdshot chorioretinopathy: IV: visual field results at baseline. Am J Ophthalmol. 2007;144(6):829-837.
13. Rothova A, Ossewaarde-van Norel A, Los LI, Berendschot TT. Efficacy of low-dosemethotrexate treatment in birdshot chorioretinopathy. Retina. 2011;31(6):1150-1155.
14. Becker MD, Wertheim MS, Smith JR, Rosenbaum JT. Long-term follow-up of patients with birdshot retinochoroidopathy treated with systemic immunosuppression. Ocul Immunol Inflamm. 2005;13(4):289-293.
15. Rush RB, Goldstein DA, Callanan DG, Meghpara B, Feuer WJ, Davis JL. Outcomes of birdshot chorioretinopathy treated with an intravitreal sustained-release fluocinolone acetonide-containing device. Am J Ophthalmol. 2011;151(4):630-636.
16. Jabs DA, Nussenblatt RB, Rosenbaum JT; Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data: results of the First International Workshop. Am J Ophthalmol. 2005;140(3):509-516. (Pubitemid 41224845)
17. Grover S, Murthy RK, Brar VS, Chalam KV. Normative data for macular thickness by high-definition spectral-domain optical coherence tomography (Spectralis). Am J Ophthalmol. 2009;148(2):266-271.
18. Fung AE, Lalwani GA, Rosenfeld PJ, et al. An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration. Am J Ophthalmol. 2007;143(4): 566-583.
19. Sobrin L, Lam BL, Liu M, Feuer WJ, Davis JL. Electroretinographic monitoring in birdshot chorioretinopathy. Am J Ophthalmol. 2005;140(1):52-64.
20. Howe LJ, Stanford MR, Graham EM, Marshall J. Choroidal abnormalities in birdshot chorioretinopathy: an indocyanine green angiography study. Eye (Lond). 1997;11(pt 4):554-559. (Pubitemid 27434992)
21. Heijl A, Buchholz P, Norrgren G, Bengtsson B. Rates of visual field progression in clinical glaucoma care. Acta Ophthalmol (Copenh). 2013;91(5): 406-412.
22. McKean-Cowdin R, Wang Y, Wu J, Azen SP, Varma R; Los Angeles Latino Eye Study Group. Impact of visual field loss on health-related quality of life in glaucoma: the Los Angeles Latino Eye Study. Ophthalmology. 2008;115(6):941-948, e1. doi:10.1016/j.ophtha.2007.08.037. (Pubitemid 351749693)
23. Tomkins-Netzer O, Taylor SR, Lightman S. Corticosteroid-sparing agents: new treatment options. Dev Ophthalmol. 2012;51:47-56.
24. Gangaputra S, Newcomb CW, Liesegang TL, et al; Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study. Methotrexate for ocular inflammatory diseases. Ophthalmology. 2009;116(11):2188-2198, e1. doi:10.1016/j.ophtha.2009. 04.020.
25. Daniel E, Thorne JE, Newcomb CW, et al. Mycophenolate mofetil for ocular inflammation. Am J Ophthalmol. 2010;149(3):423-432, e1-e2. doi:10.1016/j.ajo. 2009.09.026.
26. Kaçmaz RO, Kempen JH, Newcomb C, et al. Cyclosporine for ocular inflammatory diseases. Ophthalmology. 2010;117(3):576-584.
27. Forooghian F, Gulati N, Jabs DA. Restoration of retinal architecture following systemic immunosuppression in birdshot chorioretinopathy. Ocul Immunol Inflamm. 2010;18(6):470-471.